de la Fuente-Nunez is a presidential associate professor at the University of Pennsylvania. Skinner is CEO of the AMR Action Fund. Of all the areas of drug development that artificial intelligence has ...

Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned that we are facing an antibiotic crisis. Bacteria can easily adapt, evolve, ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

The World Health Organization (WHO) has outlined desired antibacterial characteristics for three priority infections as part of a move to direct research towards developing urgently needed antibiotics ...

Gram-negative bacteria, notorious for their antibiotic resistance, possess a formidable defense mechanism in the form of lipopolysaccharides (LPS). These large molecules, consisting of fatty acyl ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Scientists from the University of Tübingen and Monash University studied glycopeptide antibiotics, a key resource in countering drug-resistant pathogens, to uncover their evolutionary origins to gain ...

Amid a global increase in multidrug resistance, the World Health Organization (WHO) has released new guidelines that flags the lack of innovative antibiotics for vulnerable populations, as well as ...

Generative biology is moving from code to the clinic, promising faster drug discovery while raising hard questions about safety, proof and control.

Scientists have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. Two publicly-funded ...